Furthermore, the authors highlighted an incomplete understanding of the molecular mechanism of this translocation in driving AML, noting that some cases did not exhibit PVT1 involvement, as others had hypothesized [8,33]. The gene discussed is PVT1; the disease is acute myeloid leukemia.